Dad 73yrs has recurrent PC. 5 pelvic lymph nodes with hormone sensitive PC detected via rising PSA after 1.5yrs at undetectable then psma scan confirmed it was now in pelvic lymph nodes. He had his prostate removed a few years before, negative margins and just unlucky. In September last year Oncologist prescribed xtandi and lucrin for 2 years and radiation to the pelvic area. Since then PSA has dropped to the lowest it can be.Now out of the blue when my Dad was seeing the prostate surgeon for urinary issues which have resolved, the surgeon thinks my Dad should come off the therapy (10 months later) and see if his PSA should rise to 4. I'm not to happy about this I thought therspy is 18 months 2 years. Isn't that what the latest study says? Surgeon says he is concerned about the cancer mutating and becoming resistant.
He also thinks if he is to continue therapy he should switch to darolutamide for lower cognitive side effects. Dad doesn't really care about this. Again not sure if it's a bad idea.
Having conflicting advice is giving him great anxiety. He is seeing his oncologist in 2 days.
Any guidance appreciate
Written by
Jbooopin
To view profiles and participate in discussions please or .
The surgeon has it backwards. By stopping his hormone therapy now, before all the cancer cells have been destroyed, he is selecting for the more resistant strains. A STAMPEDE trial showed that 3 years of ADT with 2 years of abiraterone and radiation among men who are with cancer only in pelvic lymph nodes (stage N1), can improve survival.
IMO, it need not entail abiraterone - it can be enzalutamide, apalutamide or darolutamide - but some second generation hormonal agent appears to be necessary to get complete cell killing.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.